thats the question , but i think buyout is more likely because the company is dirt cheap thats much better than to pay royalties and big upfront payment . This one could double or triple on nasdaq ipo that where the money is so i think its better to get some now before she start trading on nasdaq .GL
Biotech Immuron tackles hospital infection Clostridium difficile
http://www.theaustralian.com.au/bus...e/news-story/4ea14aee37cb02225708603bf9a93eb1
Buyout or Big Partner Deal
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.93M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $4.519K | 44.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 120161 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 182505 | 7 |
View Market Depth
| Last trade - 12.12pm 17/07/2024 (20 minute delay) ? |
| IMC (ASX) Chart |